{"id":64264,"date":"2025-02-03T12:01:22","date_gmt":"2025-02-03T12:01:22","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2025\/02\/03\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/"},"modified":"2025-02-03T12:01:22","modified_gmt":"2025-02-03T12:01:22","slug":"ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/","title":{"rendered":"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting"},"content":{"rendered":"<div>\n<p align=\"left\">BEDFORD, Mass., Feb.  03, 2025  (GLOBE NEWSWIRE) &#8212; Ocular Therapeutix, Inc. (NASDAQ: OCUL, \u201cOcular\u201d), a biopharmaceutical company committed to redefining the retina experience, today announced upcoming presentations at the Angiogenesis, Exudation, and Degeneration 2025 virtual meeting on February 8, 2025.<\/p>\n<p><strong>Presentation Details<\/strong>:<\/p>\n<ul type=\"disc\">\n<li><strong><em>OTX-TKI From Phase 1 to Phase 3: SOL-1 and SOL-R Trials for Neovascular AMD<br \/><\/em><\/strong>Session: V: Imaging and Emerging Therapies for Exudative AMD<br \/>Presentation Time: 2:30 PM ET<br \/>Presenter: Carl J. Danzig, MD<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><strong><em>Phase 1 Results from Intravitreal Axitinib Implant (OTX-TKI) for the Treatment of Non-Proliferative Diabetic Retinopathy<br \/><\/em><\/strong>Session: VII: Diabetic Retinopathy and Retinal Vascular Diseases<br \/>Presentation Time: 5:20 PM ET<br \/>Presenter: Mark R. Barakat, MD<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li><strong><em>Volumetric Macular Fluid Analysis of the Impact of a Single Axitinib Intravitreal Implant (OTX-TKI) from the HELIOS Clinical Trial for Diabetic Retinopathy<br \/><\/em><\/strong>Session: VII: Diabetic Retinopathy and Retinal Vascular Diseases<br \/>Presentation Time: 5:25 PM ET<br \/>Presenter: Justis P. Ehlers, MD<\/li>\n<\/ul>\n<p>Exact presentation times are subject to change. Expected presentation times can be found on the Program section of the Angiogenesis, Exudation, and Degeneration 2025 conference <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0gQ3QK6f9ODaF0BMus3EE-rG_x2AWEiYyMg478UBulkCl8HJHt_dARUNoCwze4OSa6ZN8xEwHcg88EQfs1RmjZRPSQ2oDUKkLq--KzctBGCliFpLlgD0twQoHfe2wwwjzbaQ8HecVDIV3HioJh7ZErE5oOISA4sur7UAYiysu3_8Bw-DzBNS91sEVSCOVHVtK6SOpZp1NF61z4ibPS9DiQ==\" rel=\"nofollow\" target=\"_blank\" title=\"website\">website<\/a>.<\/p>\n<p><strong>About\u00a0Ocular\u00a0Therapeutix,\u00a0Inc.<\/strong><br \/>Ocular Therapeutix, Inc. is a biopharmaceutical company committed to redefining the retina experience. AXPAXLI&#x2122; (axitinib intravitreal injection, also known as OTX-TKI), Ocular\u2019s product candidate for retinal disease, is based on its ELUTYX&#x2122; proprietary bioresorbable hydrogel-based formulation technology. AXPAXLI is currently in Phase 3 clinical trials for wet age-related macular degeneration (wet AMD).<\/p>\n<p>Ocular\u2019s pipeline also leverages the ELUTYX technology in its commercial product DEXTENZA<sup>\u00ae<\/sup>, an FDA-approved corticosteroid for the treatment of ocular inflammation and pain following ophthalmic surgery and ocular itching associated with allergic conjunctivitis, and in its product candidate PAXTRAVA&#x2122; (travoprost intracameral injection or OTX-TIC), which is currently in a Phase 2 clinical trial for the treatment of open-angle glaucoma or ocular hypertension.<\/p>\n<p>Follow the Company on its website, LinkedIn, or X.<\/p>\n<p>The Ocular Therapeutix logo and DEXTENZA<sup>\u00ae<\/sup> are registered trademarks of Ocular Therapeutix, Inc. AXPAXLI&#x2122;, PAXTRAVA&#x2122;, ELUTYX&#x2122;, and Ocular Therapeutix&#x2122; are trademarks of Ocular Therapeutix, Inc.<\/p>\n<p><strong>Investors &amp; Media<\/strong><br \/>Ocular Therapeutix, Inc.<br \/>Bill Slattery<br \/>Vice President, Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RfZqIwOc2ld1paaFJPnDSEsU8jk0VKm686-kypjfXHc79YnhxVYfOMaXs_NwiWyl-Nq1ynAY-l17XTLzcgX2Gs-gG8jTWAEja5O3RDeEGqo=\" rel=\"nofollow\" target=\"_blank\" title=\"bslattery@ocutx.com\">bslattery@ocutx.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTUyNTQzN2EtYTVmYi00NDMxLThlOWUtOTU1YTk1MTBiYTBkLTEwMjI2Mjk=\/tiny\/Ocular-Therapeutix-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) &#8212; Ocular Therapeutix, Inc. (NASDAQ: OCUL, \u201cOcular\u201d), a biopharmaceutical company committed to redefining the retina experience, today announced upcoming presentations at the Angiogenesis, Exudation, and Degeneration 2025 virtual meeting on February 8, 2025. Presentation Details: OTX-TKI From Phase 1 to Phase 3: SOL-1 and SOL-R Trials for Neovascular [&#8230;]\n","protected":false},"author":1,"featured_media":64265,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-64264","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting\" \/>\n<meta property=\"og:description\" content=\"BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) &#8212; Ocular Therapeutix, Inc. (NASDAQ: OCUL, \u201cOcular\u201d), a biopharmaceutical company committed to\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-03T12:01:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Ocular-Therapeutix-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting\",\"datePublished\":\"2025-02-03T12:01:22+00:00\",\"dateModified\":\"2025-02-03T12:01:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/\"},\"wordCount\":343,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/\",\"name\":\"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2025-02-03T12:01:22+00:00\",\"dateModified\":\"2025-02-03T12:01:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting","og_description":"BEDFORD, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) &#8212; Ocular Therapeutix, Inc. (NASDAQ: OCUL, \u201cOcular\u201d), a biopharmaceutical company committed to","og_url":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2025-02-03T12:01:22+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2025\/02\/Ocular-Therapeutix-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting","datePublished":"2025-02-03T12:01:22+00:00","dateModified":"2025-02-03T12:01:22+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/"},"wordCount":343,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/","url":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/","name":"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2025-02-03T12:01:22+00:00","dateModified":"2025-02-03T12:01:22+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/ocular-therapeutix-announces-upcoming-presentations-at-the-angiogenesis-exudation-and-degeneration-2025-virtual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Ocular Therapeutix&#x2122; Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=64264"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/64264\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/64265"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=64264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=64264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=64264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}